126 related articles for article (PubMed ID: 16711022)
1. Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the expression of proliferating cell nuclear antigen and vascular endothelial growth factor in primary culture cells derived from human ovarian mucinous cystadenocarcinoma.
Li S; Liu H; Wang L; Zhu C
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(1):111-5. PubMed ID: 16711022
[TBL] [Abstract][Full Text] [Related]
2. Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the cell proliferation and apoptosis in cells derived from human ovarian mucinous cystadenocarcinoma in Vitro.
Li S; Ma D; Zhu C
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):95-100. PubMed ID: 17393121
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligodeoxynucleotide inhibits expression of recombinant porcine follicle-stimulating hormone receptor.
Zhu C; Nixon MD; Wang Y; LaBarbera AR
J Tongji Med Univ; 1999; 19(3):175-80. PubMed ID: 12840888
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligodeoxynucleotide inhibits expression of recombinant porcine follicle-stimulating hormone receptor.
Zhu C; Wang Y; Nixon MD; La Barbera AR
Mol Reprod Dev; 2003 Jun; 65(2):188-93. PubMed ID: 12704730
[TBL] [Abstract][Full Text] [Related]
5. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM; Lau KM; Mok SC; Syed V
Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligodeoxynucleotide inhibits vascular endothelial growth factor in human glioma cells.
Zheng SX; Zhou LJ; Zhu XZ; Jin YX
Acta Pharmacol Sin; 2000 Mar; 21(3):211-4. PubMed ID: 11324417
[TBL] [Abstract][Full Text] [Related]
7. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
[TBL] [Abstract][Full Text] [Related]
8. Follicle-stimulating hormone promotes nerve growth factor and vascular endothelial growth factor expression in epithelial ovarian cells.
Garrido MP; Bruneau N; Vega M; Selman A; Tapia JC; Romero C
Histol Histopathol; 2020 Sep; 35(9):961-971. PubMed ID: 32369181
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Yangjing Zhongyu Decoction on mRNA and protein expression of PCNA, StAR, and FSHR in ovarian granulosa cells cultured by excess androgen].
Zheng YH; Ding T; Ma HX; Ye DF; Su NJ; Wu XK
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):312-6. PubMed ID: 24758083
[TBL] [Abstract][Full Text] [Related]
10. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer.
Parrott JA; Doraiswamy V; Kim G; Mosher R; Skinner MK
Mol Cell Endocrinol; 2001 Feb; 172(1-2):213-22. PubMed ID: 11165055
[TBL] [Abstract][Full Text] [Related]
11. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells].
Lu JP; Sun H; Cao CC; Ou ZL
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352
[TBL] [Abstract][Full Text] [Related]
12. [VEGF antisense oligonucleotide inhibits the expression of vascular endothelial growth factor in human leukemic cell lines].
Zhang L; Tu ZG; Feng WL; Huang ZG
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):22-5. PubMed ID: 14990072
[TBL] [Abstract][Full Text] [Related]
13. FSH-regulated gene expression profiles in ovarian tumours and normal ovaries.
Chu S; Rushdi S; Zumpe ET; Mamers P; Healy DL; Jobling T; Burger HG; Fuller PJ
Mol Hum Reprod; 2002 May; 8(5):426-33. PubMed ID: 11994539
[TBL] [Abstract][Full Text] [Related]
14. Optimal FSH usage in revascularization of allotransplanted ovarian tissue in mice.
Ma WZ; Zheng XM; Hei CC; Zhao CJ; Xie SS; Chang Q; Cai YF; Jia H; Pei XY; Wang YR
J Ovarian Res; 2017 Jan; 10(1):5. PubMed ID: 28095884
[TBL] [Abstract][Full Text] [Related]
15. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
[TBL] [Abstract][Full Text] [Related]
16. Antisense-mediated VEGF suppression in bladder and breast cancer cells.
Förster Y; Meye A; Krause S; Schwenzer B
Cancer Lett; 2004 Aug; 212(1):95-103. PubMed ID: 15246565
[TBL] [Abstract][Full Text] [Related]
17. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
Shi HR; Song WJ; Chen ZM; Wu QH
Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
[TBL] [Abstract][Full Text] [Related]
19. Effects of growth differentiation factor-9 and FSH on in vitro development, viability and mRNA expression in bovine preantral follicles.
Vasconcelos GL; Saraiva MV; Costa JJ; Passos MJ; Silva AW; Rossi RO; Portela AM; Duarte AB; Magalhães-Padilha DM; Campelo CC; Figueiredo JR; van den Hurk R; Silva JR
Reprod Fertil Dev; 2013; 25(8):1194-203. PubMed ID: 23241220
[TBL] [Abstract][Full Text] [Related]
20. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
Xu CL; Lu XL; Yan XN; Wang HL; Chen SQ
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):134-8. PubMed ID: 22455747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
